Biocept Inc (CE) (BIOCQ) Cotización

nah.

BIOC changed to BIOCQ, bankruptcy. Delisted from the Nasdaq to the OTC:

https://otce.finra.org/otce/dailyList?viewType=Additions

Files for Bankruptcy and goes Up...Hmmm.WTF....>>>

BACK TO .80

Zombie stocks;)~

IT$ VIDEO GAME TRADING MANIA 2023

Certainly makes no sense that I could see. Must've missed something. Lol!

Dog's of war...>>>

Antonino Morales, Marsha A. Chandler, Bruce E. Gerhardt, Quyen Dao-Haddock, Ivor Royston, and Linda Rubinstein (each a “Member” and collectively the “Members”) tendered their resignations as members of the Company’s Board of Directors which resignations were effective on October 13, 2023, prior to filing the Petition. The resignations of Mr. Morales, Ms. Chandler, Mr. Gerhardt, Ms. Dao-Haddock, Mr. Royston and Ms. Rubinstein are not the result of any disagreements with the Company regarding the Company’s operations, policies, or practices. Each of the Members have resigned due to the Company’s filing of the Petition which effectively eliminates the powers of the Company’s Board of Directors. Following the resignations of the Members, the Company will have no members serving on its Board of Directors.



In addition to his resignation from the Company’s Board of Directors, Mr. Morales tendered his resignation as the Company’s President and Chief Executive Officer effective on October 13, 2023. The resignation of Mr. Morales was not the result of any disagreement with the Company regarding the Company’s operations, policies, or practices. Mr. Morales resigned due to the filing of the Petition which effectively eliminates the powers he previously held on behalf of the Company and the roles of President and Chief Executive Officer.

THIS IS CRAZEEEE

LOL

BIOC new 52 week low

After considering strategic alternatives, Biocept, Inc., a Delaware corporation (the “Company”), filed a voluntary petition for relief (the “Petition”) under the provisions of Chapter 7 of Title 11 of the United States Code, 11 U.S.C. §§ 101 et seq. (the “Code”) in the United States Bankruptcy Court for the District of Delaware (the “Bankruptcy Court”) on October 13, 2023

aka WHY NOT~!

Selling the huge GAP on the news ...

TY LETS HAVE A GREAT $$$ DAY

up 100% pre mkt!Nice find bro!

$BIOC $PVST NEWS https://finance.yahoo.com/news/biocept-signs-cnside-licensing-agreement-120000884.html

https://dilutiontracker.com/app/search/BIOC

BIOC new 52 week low

Something going on with volume

Impressive for a trader. LT Investment here has been a nightmare

BIOC..............................https://stockcharts.com/h-sc/ui?s=BIOC&p=W&b=5&g=0&id=p86431144783

Bioc dirtbags most likely committed the biggest CoVid fraud of 2020. They may have liability of over 200 million dollars.

Auditor was in on it….

Ceo…fired

Cfo…fired

Company attorney….. gone


Financials now unaudited

Aegea has for sure stolen at least one Biocept trade secret

Dumbass. Biocept CEO,CFO and Council fired! You heard it here first. Next the Board members. Then the Auditor and next Biocept's attorney Cooley. They all committed fraud or when notified of the fraud failed to correct it.

And it is Aegea's patents that they let Biocept have 50% of. Biocept has nothing. And when my lawsuit hits with exhibits and affidavits they will be lucky to get financing.

Aegea has been smooching off Biocept’s R&D efforts and will continue…Aegea is not a real company!

Interesting news, TUAG is a public company that owns a small percentage of Aegea. Biocept has the first right to negotiate a licensing deal.

I think Aegea is about to become huge value, especially given the news. Both these public companies should benefit

Knock knock.

Nall and the BOD is not going to like what is coming their way. Scammers

This ship is going down….

Relatively good news yesterday but it shit the bed. Is today the day it reacts?

This is ready to move. With a little volume she's going to $5+

Aegea is not a real company,……..using Biocept resources since 2011!!!

And the faucet gets turned back on

10K Out. Oopsie Doopsie. Auditor had to sign this one and they made material changes to previous footnotes signed by off on by Nall and Kennedy.

Gonna get interesting, last thing we need is the proxy.

CEO Michael Nall is a Covid scammer my friend. Not only has he and Biocept CFO Timothy Kennedy been caught red handed committing intentional fraud in SEC filings, they concealed material news from investors. Get ready for another Nall financing.

Nall keeps doubling down on his lies, as he stated that the company announced a supply agreement with Aegea. Well, I do not see a biocept press release or an 8K to that effect. Furthermore, Nall stated that Biocept and Aegea co own Switch Blocker patents decieving investors that Biocept coowns those patents outside of a few oncology indications. This guy is a real piece of work..

Covid testing is going to fall of the cliff, and nearly 95% of the revenue was Covid testing...


In regards to our collaboration with the Aegea Biotechnologies, earlier this month, after successfully developing a next-generation COVID-19 assay, we announced a supply agreement under which Aegea is providing us with the kits for validation and commercialization in our lab. This next-generation COVID-19 assay was developed using the patented Switch-Blocker technology that is jointly owned by Biocept and Aegea, which is the same technology that is the basis for many of our ultrasensitive oncology assays. Our current COVID-19 RT-PCR testing provides qualitative results only, meaning that sample is either positive or negative. The new codeveloped assay has the advantage of distinguishing various strains of the virus while providing quantitative viral load results. Healthcare providers can use this quantitative assay to monitor viral load over time in order to determine when a patient, a resident, student or employee can safely return to the general population. This new assay can also be modified to detect new variants of the SARS-CoV-2 virus as they emerge.

$BIOC is screaming for the top after announcing its financial results for the fourth quarter and full 2020 year. https://cnafinance.com/bioc-stock-biocept-climbs-on-financial-results/

Gonna be curious to see how auditor gets around fraud in Q's when they actually have to sign off on the annual report. Not a big surprise that there have not been any SEC filings in a while.

Hmmm. Still not an SEC filing done by the Company since it was pointed out the auditor was in on it to.

Is it true not only that Nall loaded up on 241,000 options at a huge discount to the the August high after he did what looks like an unlawful reverse split; but Nall also took a huge cash bonus for all those financings.

Pretty interesting how Nall could do not only one offering last March, but that he did a second one because the first one was oversubscribed. Pretty amazing Nall could do that when the markets were crashing from a pandemic and the company was bleeding cash.

Quite a talented CEO

$bioc $6.03 v -0.09 (-1.47%)
Volume: 275,930 @03/12/21 7:38:58 PM EST

Ready for the pump and finance at a 50 percent discount. Any day now.

$bioc $5.3 v -0.03 (-0.56%)
Volume: 516,292 @03/05/21 7:20:08 PM EST

How is the week in BIOC going... LOL I am out at earnings cause they will pump the price. That idiot Nall is probably doing a financing at $3.00 today to ream shareholders.

Sell the pump... What do you think the odds are Nall will be CEO in 3 -6 months....LOL

Right

Can you help me with this question, if Aegea test kit is as good as we think it it is, and considering testing hysteria is on the decline, why would Aegea hook its wagons to Biocept. Aegea know the fraud committed by Biocept.

How did Aegea do hooking its wagaons to Biocpt for liquid biopsy testing, not that good eh. Other liquid biopsy companies get bought for billions and Biocept is always under water and Biocept pays them pathetic royalties. Aegea's CEO Arnold Biocept's options have been reversed split 4 times and the strike price is most likely north of $40.

For a bunch of reasons I can see Aegea letting Biocept be a seller of the test kit. Big Whoopie.

Maybe, but the press release it typical bullskat.

1. The Aegea test should had an EUA last yr but Nall was incompetent and didn't think Covid testing would last. Because of that they now have had to get cleared which caused delays. A test last September would have had a greater meaining pre vaccine rollout

2. This press release is no different than the one in August that was used to pump the stock to get enough votes to approve a reverse split. Nall tanked the stock with a reverse split and then gave himself 241,000 options at 75% less than the price per share of the first aegea announcement

3. The stock price was higher last febuary before Nall announced Covid testing, the BS VEESure, the Aegea announcements or the new hospital affilaitions for the liquid biopsy.

4. Nall, kennedy and the BOD committed fraud, and the outside attorney and auditor must be in on it because they have not corrected it. Probably because of the class action lawsuit that will have a couple of these execs working a $10.00 an hour job.

Biocept is a good company, lots of hard working people. Stay tuned. I am long till earnings.

This will be the month of pumps and then massive financing because they bleed cash even with Covid testing revenues.

The Aegea announcement does not give them and excusive to sell the test nor does it give them any patent ownership. Typical Biocept press release.

And the news just dropped. Should be a great week

$bioc $10 with news

Whoo Hoo.. News, like VeeSure, Aegea test kit or that they have now done 200,000 Covid tests... Sure it will go up and then a $10, $20, $30 million dollar financing will be disclosed after hours.


And if the past proves the future the stock will tank in after hours, the past shows it tanking 50% off the high of the day and then a financing will be done.

Is it true the CEO Nall received $3 million plus bonus for doing the financings the last year. It is not to hard to raise money when you do it at half price with news in your back pocket.

It sure is trus CEO Nall granted himself 241,000 options at $4.40 (.45 pps pre reverse split) a share after the stock was $13 (1.30 pps pre reverse split)

TIC TOC..

For reference, the stock price hit $7.80 last Febuary before any CoVid testing, VeeSure or Aegea test kit announcement.

The stock price was $13 last August on the Aegea test kit news. Yet despite all the testing, which according to a press release a few months ago was 25,000,000 tests ($25,000,000 in revenue) plus the VeeSure plus the Aegea test kit the stock is still at $6.50 (or .65 before the reverse split)

maybe you $10, $12 but one doesn't need a crystal ball to see a financing in the future. Small companies need financing for sure, but BIOC has a liquid biopsy product that has been out for a while and all they do is lose money. Testing for covid will slow down by EOY.

$bioc $10 with news

$bioc $7.28 v -0.13 (-1.75%)
Volume: 252,442 @02/12/21 7:45:51 PM EST